Skip to main content

Table 1 Data collection schedule

From: A phase II open label, single arm study of hypofractionated stereotactic radiotherapy with chemoradiotherapy using intensity-modulated radiotherapy for newly diagnosed glioblastoma after surgery: the HSCK-010 trial protocol

  Inclusion Surgery RT M2 M4 M6 Mxa
Medical History       
Physical examinations and vital signs   
Blood routine, Hepatic and Renal Function
Pregnancy Test (Childbearing Age Women)       
Dosimetric MRI + CT Scan        
MRI (T1 enhanced, T2 FLAIR)    
KPS Score
QLQ-C30 questionnaire
MMSE questionnaire
Toxicity Evaluation (CTCAE 5.0)
  1. aThe follow-up will be done every two months till death or the patient withdrawal from the study